Publication: Safety and efficacy of ponatinib in real world clinical practice. Results from the Spanish Compassionate Use Program. A GELMC study
Identifiers
Date
2016-06
Authors
Valentin, GG
Hernandez-Boluda, JC
Osorio, S
Correa, JG
Sanchez-Guijo, F
Gómez-Casares, MT
Durán, S
Portero, MA
Boqué, C
Pérez-Encinas, M
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Ferrata Storti Foundation
Metrics
Export
Abstract
Aims: The purpose of this study is to provide safety and efficacy information
from patients treated with ponatinib in real world clinical practice.
Description
MeSH Terms
Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Azoles::Imidazoles
Medical Subject Headings::Diseases::Hemic and Lymphatic Diseases::Hematologic Diseases::Bone Marrow Diseases::Myeloproliferative Disorders::Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Pyridazines
Medical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Probability::Risk
Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Azoles::Imidazoles
Medical Subject Headings::Diseases::Hemic and Lymphatic Diseases::Hematologic Diseases::Bone Marrow Diseases::Myeloproliferative Disorders::Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Pyridazines
Medical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Probability::Risk
DeCS Terms
CIE Terms
Keywords
Humanos, Imidazoles, Leucemia mielogenosa crónica BCR-ABL positiva, Piridacinas, Riesgo
Citation
Valentin GG, Hernandez-Boluda JC, Osorio S, Correa JG, Sanchez-Guijo F, Gómez-Casares MT, et al.Safety and efficacy of ponatinib in real world clinical practice. Results from the Spanish Compassionate Use Program. A GELMC study. Haematologica. 2016; 101 (s1) PB1832